Cyclic GMP-dependent protein kinase. targeting and control of expression

Thomas M. Lincoln, Hassan Sellak, Nupur Dey, Chung Sik Choi, Felricia Brown

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter addresses three aspects of PKG function that include the role of PKG-I targeting to subcellular proteins especially in smooth muscle cells (SMC), the role of PKG-I in regulating vascular SMC (VSMC) gene expression, and the regulation of the expression of PKG-I. The serum response factor (SRF) interacts with numerous co-transcriptional regulators, including myocardin, a smooth muscle specific co-transcription factor and member of the larger myocardin-related factor (MRF) family of proteins. PKG-I enhances myocardin-stimulated SRF activity in part through the phosphorylation of a myocardin regulatory protein, cysteine-rich protein-2 (CRP-2) in VSMC. The enhanced myocardin-dependent SRF activity in a non-smooth muscle cell line is observed, when it is transfected with myocardin and PKG-I cDNA. PKG-I also increases SRF binding to smooth muscle-specific promoter regions of SMMHC and SM22. The Kruppel-like factor (KLF-4) binds to the Sp1 sites on the PKG-I proximal promoter and regulates gene transcription. The small molecular weight G proteins, RhoA and rac, regulate KLF-4 binding and PKG-I gene expression. The inflammatory, atherogenic cytokines such as IL-1? and TNFα decrease PKG-I mRNA and protein levels in bovine aortic VSMC. One mechanism responsible for this event is a cytokine-dependent increase in iNOS expression, NO biosynthesis, and a decrease in Sp1 binding to the PKG-I promoter. Suppression of iNOS activity or sGC activity inhibits the downregulation of PKG-I mRNA induced by the cytokines. PKA inhibition also suppresses the effects of cytokines on PKG-I mRNA expression, suggesting that high elevations in cGMP in response to iNOS expression cross-activate PKA and lead to decreased Sp1 protein binding to the PKG-I promoter.

Original languageEnglish (US)
Title of host publicationHandbook of Cell Signaling, 2/e
PublisherElsevier Inc.
Pages1471-1477
Number of pages7
Volume2
ISBN (Print)9780123741455
DOIs
StatePublished - Dec 1 2010

Fingerprint

Cyclic GMP-Dependent Protein Kinases
Serum Response Factor
Muscle
Cytokines
Proteins
Gene expression
Messenger RNA
Smooth Muscle Myocytes
Smooth Muscle
Blood Vessels
rac GTP-Binding Proteins
Cells
Kruppel-Like Transcription Factors
Phosphorylation
Biosynthesis
Gene Expression Regulation
Transcription
Interleukin-1
Vascular Smooth Muscle
GTP-Binding Proteins

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Lincoln, T. M., Sellak, H., Dey, N., Choi, C. S., & Brown, F. (2010). Cyclic GMP-dependent protein kinase. targeting and control of expression. In Handbook of Cell Signaling, 2/e (Vol. 2, pp. 1471-1477). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-374145-5.00180-7

Cyclic GMP-dependent protein kinase. targeting and control of expression. / Lincoln, Thomas M.; Sellak, Hassan; Dey, Nupur; Choi, Chung Sik; Brown, Felricia.

Handbook of Cell Signaling, 2/e. Vol. 2 Elsevier Inc., 2010. p. 1471-1477.

Research output: Chapter in Book/Report/Conference proceedingChapter

Lincoln, TM, Sellak, H, Dey, N, Choi, CS & Brown, F 2010, Cyclic GMP-dependent protein kinase. targeting and control of expression. in Handbook of Cell Signaling, 2/e. vol. 2, Elsevier Inc., pp. 1471-1477. https://doi.org/10.1016/B978-0-12-374145-5.00180-7
Lincoln TM, Sellak H, Dey N, Choi CS, Brown F. Cyclic GMP-dependent protein kinase. targeting and control of expression. In Handbook of Cell Signaling, 2/e. Vol. 2. Elsevier Inc. 2010. p. 1471-1477 https://doi.org/10.1016/B978-0-12-374145-5.00180-7
Lincoln, Thomas M. ; Sellak, Hassan ; Dey, Nupur ; Choi, Chung Sik ; Brown, Felricia. / Cyclic GMP-dependent protein kinase. targeting and control of expression. Handbook of Cell Signaling, 2/e. Vol. 2 Elsevier Inc., 2010. pp. 1471-1477
@inbook{f17801779e93448caf75ab8e29cf0f13,
title = "Cyclic GMP-dependent protein kinase. targeting and control of expression",
abstract = "This chapter addresses three aspects of PKG function that include the role of PKG-I targeting to subcellular proteins especially in smooth muscle cells (SMC), the role of PKG-I in regulating vascular SMC (VSMC) gene expression, and the regulation of the expression of PKG-I. The serum response factor (SRF) interacts with numerous co-transcriptional regulators, including myocardin, a smooth muscle specific co-transcription factor and member of the larger myocardin-related factor (MRF) family of proteins. PKG-I enhances myocardin-stimulated SRF activity in part through the phosphorylation of a myocardin regulatory protein, cysteine-rich protein-2 (CRP-2) in VSMC. The enhanced myocardin-dependent SRF activity in a non-smooth muscle cell line is observed, when it is transfected with myocardin and PKG-I cDNA. PKG-I also increases SRF binding to smooth muscle-specific promoter regions of SMMHC and SM22. The Kruppel-like factor (KLF-4) binds to the Sp1 sites on the PKG-I proximal promoter and regulates gene transcription. The small molecular weight G proteins, RhoA and rac, regulate KLF-4 binding and PKG-I gene expression. The inflammatory, atherogenic cytokines such as IL-1? and TNFα decrease PKG-I mRNA and protein levels in bovine aortic VSMC. One mechanism responsible for this event is a cytokine-dependent increase in iNOS expression, NO biosynthesis, and a decrease in Sp1 binding to the PKG-I promoter. Suppression of iNOS activity or sGC activity inhibits the downregulation of PKG-I mRNA induced by the cytokines. PKA inhibition also suppresses the effects of cytokines on PKG-I mRNA expression, suggesting that high elevations in cGMP in response to iNOS expression cross-activate PKA and lead to decreased Sp1 protein binding to the PKG-I promoter.",
author = "Lincoln, {Thomas M.} and Hassan Sellak and Nupur Dey and Choi, {Chung Sik} and Felricia Brown",
year = "2010",
month = "12",
day = "1",
doi = "10.1016/B978-0-12-374145-5.00180-7",
language = "English (US)",
isbn = "9780123741455",
volume = "2",
pages = "1471--1477",
booktitle = "Handbook of Cell Signaling, 2/e",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Cyclic GMP-dependent protein kinase. targeting and control of expression

AU - Lincoln, Thomas M.

AU - Sellak, Hassan

AU - Dey, Nupur

AU - Choi, Chung Sik

AU - Brown, Felricia

PY - 2010/12/1

Y1 - 2010/12/1

N2 - This chapter addresses three aspects of PKG function that include the role of PKG-I targeting to subcellular proteins especially in smooth muscle cells (SMC), the role of PKG-I in regulating vascular SMC (VSMC) gene expression, and the regulation of the expression of PKG-I. The serum response factor (SRF) interacts with numerous co-transcriptional regulators, including myocardin, a smooth muscle specific co-transcription factor and member of the larger myocardin-related factor (MRF) family of proteins. PKG-I enhances myocardin-stimulated SRF activity in part through the phosphorylation of a myocardin regulatory protein, cysteine-rich protein-2 (CRP-2) in VSMC. The enhanced myocardin-dependent SRF activity in a non-smooth muscle cell line is observed, when it is transfected with myocardin and PKG-I cDNA. PKG-I also increases SRF binding to smooth muscle-specific promoter regions of SMMHC and SM22. The Kruppel-like factor (KLF-4) binds to the Sp1 sites on the PKG-I proximal promoter and regulates gene transcription. The small molecular weight G proteins, RhoA and rac, regulate KLF-4 binding and PKG-I gene expression. The inflammatory, atherogenic cytokines such as IL-1? and TNFα decrease PKG-I mRNA and protein levels in bovine aortic VSMC. One mechanism responsible for this event is a cytokine-dependent increase in iNOS expression, NO biosynthesis, and a decrease in Sp1 binding to the PKG-I promoter. Suppression of iNOS activity or sGC activity inhibits the downregulation of PKG-I mRNA induced by the cytokines. PKA inhibition also suppresses the effects of cytokines on PKG-I mRNA expression, suggesting that high elevations in cGMP in response to iNOS expression cross-activate PKA and lead to decreased Sp1 protein binding to the PKG-I promoter.

AB - This chapter addresses three aspects of PKG function that include the role of PKG-I targeting to subcellular proteins especially in smooth muscle cells (SMC), the role of PKG-I in regulating vascular SMC (VSMC) gene expression, and the regulation of the expression of PKG-I. The serum response factor (SRF) interacts with numerous co-transcriptional regulators, including myocardin, a smooth muscle specific co-transcription factor and member of the larger myocardin-related factor (MRF) family of proteins. PKG-I enhances myocardin-stimulated SRF activity in part through the phosphorylation of a myocardin regulatory protein, cysteine-rich protein-2 (CRP-2) in VSMC. The enhanced myocardin-dependent SRF activity in a non-smooth muscle cell line is observed, when it is transfected with myocardin and PKG-I cDNA. PKG-I also increases SRF binding to smooth muscle-specific promoter regions of SMMHC and SM22. The Kruppel-like factor (KLF-4) binds to the Sp1 sites on the PKG-I proximal promoter and regulates gene transcription. The small molecular weight G proteins, RhoA and rac, regulate KLF-4 binding and PKG-I gene expression. The inflammatory, atherogenic cytokines such as IL-1? and TNFα decrease PKG-I mRNA and protein levels in bovine aortic VSMC. One mechanism responsible for this event is a cytokine-dependent increase in iNOS expression, NO biosynthesis, and a decrease in Sp1 binding to the PKG-I promoter. Suppression of iNOS activity or sGC activity inhibits the downregulation of PKG-I mRNA induced by the cytokines. PKA inhibition also suppresses the effects of cytokines on PKG-I mRNA expression, suggesting that high elevations in cGMP in response to iNOS expression cross-activate PKA and lead to decreased Sp1 protein binding to the PKG-I promoter.

UR - http://www.scopus.com/inward/record.url?scp=84882821650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882821650&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-374145-5.00180-7

DO - 10.1016/B978-0-12-374145-5.00180-7

M3 - Chapter

SN - 9780123741455

VL - 2

SP - 1471

EP - 1477

BT - Handbook of Cell Signaling, 2/e

PB - Elsevier Inc.

ER -